Search Results - "Traub-Weidinger, Tatjana"

From Compassionate Use Toward High-Level Evidence for Radiopharmaceutical Therapy in Recurrent Meningioma: The LUMEN-1 and MOMENTUM-1 Trials.

Authors: Tolboom, Nelleke Albert, Nathalie L. Braat, Arthur J.A.T. et al.

Source: Journal of Nuclear Medicine. Jan2026, Vol. 67 Issue 1, p19-22. 4p.

EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy.

Authors: Traub-Weidinger, Tatjana Arbizu, Javier Barthel, Henryk et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Jun2024, Vol. 51 Issue 7, p1891-1908. 18p.

Perspectives of the European Association of Nuclear Medicine on the role of artificial intelligence (AI) in molecular brain imaging.

Authors: Fraioli, Francesco Albert, Nathalie Boellaard, Ronald et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Mar2024, Vol. 51 Issue 4, p1007-1011. 5p.

Neuroimaging biomarkers in the biological definition of Parkinson's disease and dementia with Lewy bodies – EANM position on current state, unmet needs and future perspectives.

Authors: Brendel, Matthias Guedj, Eric Yakushev, Igor et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Oct2024, Vol. 51 Issue 12, p3496-3500. 5p.

Lecanemab approval in EU: what should we be ready for?– the EANM perspective.

Authors: Yakushev, Igor Verger, Antoine Brendel, Matthias et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Apr2025, Vol. 52 Issue 5, p1607-1610. 4p.

Correction to: EANM perspectives for CZT SPECT in brain applications.

Authors: Verger, Antoine Cecchin, Diego Guedj, Eric et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Oct2024, Vol. 51 Issue 12, p3807-3807. 1p.

EANM position on positron emission tomography in suspected functional pituitary neuroendocrine tumours.

Authors: Van Weehaeghe, Donatienne Lapauw, Bruno Fraioli, Francesco et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Jul2024, Vol. 51 Issue 8, p2367-2370. 4p.

Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0.

Authors: Albert, Nathalie L. Preusser, Matthias Traub-Weidinger, Tatjana et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Oct2024, Vol. 51 Issue 12, p3662-3679. 18p.

EANM perspectives for CZT SPECT in brain applications.

Authors: Verger, Antoine Cecchin, Diego Guedj, Eric et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Oct2024, Vol. 51 Issue 12, p3680-3684. 5p.

Proven validity and management impact of amyloid imaging in Alzheimer's disease—repetita juvant.

Authors: Barthel, Henryk Arbizu, Javier Drzezga, Alexander et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Jul2020, Vol. 47 Issue 8, p1787-1790. 4p.

EANM position paper: theranostics in brain tumours—the present and the future.

Authors: Tolboom, Nelleke Verger, Antoine Albert, Nathalie L. et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Dec2023, Vol. 51 Issue 1, p202-205. 4p.

Correction to: EANM procedure guidelines for brain PET imaging using [¹⁸F]FDG, version 3.

Authors: Guedj, Eric Varrone, Andrea Boellaard, Ronald et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. May2022, Vol. 49 Issue 6, p2100-2101. 2p.

FDA approval of lecanemab: the real start of widespread amyloid PET use? — the EANM Neuroimaging Committee perspective.

Authors: Verger, Antoine Yakushev, Igor Albert, Nathalie L. et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. May2023, Vol. 50 Issue 6, p1553-1555. 3p.

Clinical heterogeneity within the ALS‐FTD spectrum in a family with a homozygous optineurin mutation.

Authors: Parvizi, Tandis Klotz, Sigrid Keritam, Omar et al.

Source: Annals of Clinical & Translational Neurology. Jun2024, Vol. 11 Issue 6, p1579-1589. 11p.

EANM perspective on clinical PET and SPECT imaging in schizophrenia-spectrum disorders: a systematic review of longitudinal studies.

Authors: Rogeau, Antoine Boer, Anne Jetske Guedj, Eric et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Feb2025, Vol. 52 Issue 3, p876-899. 24p.

Real‐world performance of plasma p‐tau181 in a heterogeneous memory clinic cohort.

Authors: Parvizi, Tandis Wurm, Raphael König, Theresa et al.

Source: Annals of Clinical & Translational Neurology. Aug2024, Vol. 11 Issue 8, p1988-1998. 11p.

Validation of cardiac image-derived input functions for functional PET quantification.

Authors: Reed, Murray Bruce Handschuh, Patricia Anna Schmidt, Clemens et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Jul2024, Vol. 51 Issue 9, p2625-2637. 13p.

High-temporal resolution functional PET/MRI reveals coupling between human metabolic and hemodynamic brain response.

Authors: Hahn, Andreas Reed, Murray B. Vraka, Chrysoula et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Apr2024, Vol. 51 Issue 5, p1310-1322. 13p.

COVID-19 and the brain: impact on nuclear medicine in neurology.

Authors: Morbelli, Silvia Ekmekcioglu, Ozgul Barthel, Henryk et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Oct2020, Vol. 47 Issue 11, p2487-2492. 6p.

Impact of SSTR PET on Inter-Observer Variability of Target Delineation of Meningioma and the Possibility of Using Threshold-Based Segmentations in Radiation Oncology.

Authors: Kriwanek, Florian Ulbrich, Leo Lechner, Wolfgang et al.

Source: Cancers. Sep2022, Vol. 14 Issue 18, pN.PAG-N.PAG. 11p.